A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial. (2017)
Attributed to:
MICA: Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/humrep/dex253
PubMed Identifier: 28854728
Publication URI: http://europepmc.org/abstract/MED/28854728
Type: Journal Article/Review
Volume: 32
Parent Publication: Human reproduction (Oxford, England)
Issue: 9
ISSN: 0268-1161